Enhanced frontal function in Parkinson's disease.

We investigated the role of dopamine in working memory by examining effects of withdrawing dopaminergic medication in patients with Parkinson's disease. Resistance to distraction during a delayed response task was abnormally enhanced in Parkinson's disease patients OFF medication relative to controls. Conversely, performance on a backward digit span test was impaired in these same Parkinson's disease patients OFF medication. Dopaminergic medication reinstated susceptibility to distraction and backward digit span performance, so that performance of Parkinson's disease patients ON medication did not differ from that of controls. We hypothesize that the enhanced distractor resistance and impaired backward digit span in Parkinson's disease reflects low dopamine levels in the striatum, and perhaps upregulated frontal dopamine levels. Dopaminergic medication may reinstate distractibility by normalizing the balance between striatal and prefrontal dopamine transmission.

[1]  Y Agid,et al.  Are dopaminergic neurons selectively vulnerable to Parkinson's disease? , 1993, Advances in neurology.

[2]  V Kaasinen,et al.  Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex. , 2001, Brain : a journal of neurology.

[3]  C. Marsden,et al.  'Subcortical dementia': the neuropsychological evidence. , 1988, Neuroscience.

[4]  C. Carter,et al.  Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats , 1980, Nature.

[5]  A. Lees,et al.  Cognitive deficits in the early stages of Parkinson's disease. , 1983, Brain : a journal of neurology.

[6]  T. Klingberg,et al.  Prefrontal cortex and basal ganglia control access to working memory , 2008, Nature Neuroscience.

[7]  T. Robbins,et al.  Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. , 2001, Cerebral cortex.

[8]  Karl J. Friston,et al.  Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study. , 1999, Brain : a journal of neurology.

[9]  J. Patton,et al.  Factor structure of the Barratt impulsiveness scale. , 1995, Journal of clinical psychology.

[10]  M. Petrides,et al.  Cortical activity in Parkinson's disease during executive processing depends on striatal involvement. , 2006, Brain : a journal of neurology.

[11]  V. Preedy,et al.  Unified Parkinson's Disease Rating Scale , 2010 .

[12]  B. Kolachana,et al.  Catechol-O-Methyltransferase Genotype and Dopamine Regulation in the Human Brain , 2003, The Journal of Neuroscience.

[13]  M. Mehta,et al.  Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson’s disease , 2004, Neuropsychologia.

[14]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[15]  S. Fahn.  Unified Parkinson's Disease Rating Scale , 1987 .

[16]  T. Robbins,et al.  Differential Responses in Human Striatum and Prefrontal Cortex to Changes in Object and Rule Relevance , 2004, The Journal of Neuroscience.

[17]  Michael J. Frank,et al.  Dynamic Dopamine Modulation in the Basal Ganglia: A Neurocomputational Account of Cognitive Deficits in Medicated and Nonmedicated Parkinsonism , 2005, Journal of Cognitive Neuroscience.

[18]  Clayton E. Curtis,et al.  Differential effects of distraction during working memory on delay-period activity in the prefrontal cortex and the visual association cortex , 2006, NeuroImage.

[19]  Richard B. Ivry,et al.  The Human Striatum is Necessary for Responding to Changes in Stimulus Relevance , 2006, Journal of Cognitive Neuroscience.

[20]  A C Roberts,et al.  6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[21]  Thomas E. Hazy,et al.  Banishing the homunculus: Making working memory work , 2006, Neuroscience.

[22]  T. Robbins,et al.  Mechanisms of cognitive set flexibility in Parkinson's disease. , 2001, Brain : a journal of neurology.

[23]  R. Cools.  Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease , 2006, Neuroscience & Biobehavioral Reviews.

[24]  Chris Rorden,et al.  Spatial Normalization of Brain Images with Focal Lesions Using Cost Function Masking , 2001, NeuroImage.

[25]  M. D’Esposito,et al.  Impulsive Personality Predicts Dopamine-Dependent Changes in Frontostriatal Activity during Component Processes of Working Memory , 2007, The Journal of Neuroscience.

[26]  C. Kennard,et al.  Memory-motor transformations are impaired in Parkinson's disease , 2003, Experimental Brain Research.

[27]  T. Robbins,et al.  l-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease , 2003, Neuropsychologia.

[28]  Arthur L. Benton,et al.  Differential behavioral effects in frontal lobe disease , 1968 .

[29]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[30]  R. Knight,et al.  Human prefrontal lesions increase distractibility to irrelevant sensory inputs , 1995, Neuroreport.

[31]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[32]  T. Robbins,et al.  Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease , 2005, Neuropsychologia.

[33]  T. Robbins,et al.  The effect of dopamine depletion from the caudate nucleus of the common marmoset (Callithrix jacchus) on tests of prefrontal cognitive function. , 2000, Behavioral neuroscience.

[34]  N. Sawamoto,et al.  Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. , 2008, Brain : a journal of neurology.

[35]  R. Nussbaum,et al.  Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype , 2005, Nature Neuroscience.

[36]  L. Nyberg,et al.  Temporal dynamics of basal ganglia under-recruitment in Parkinson's disease: transient caudate abnormalities during updating of working memory. , 2008, Brain : a journal of neurology.

[37]  A. M. Owen,et al.  Visuospatial memory deficits at different stages of Parkinson's disease , 1993, Neuropsychologia.

[38]  M. M. Burns,et al.  Parkinsonism , 1975, Neurology.

[39]  T. Sejnowski,et al.  Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. , 2000, Journal of neurophysiology.

[40]  Roshan Cools,et al.  Using executive heterogeneity to explore the nature of working memory deficits in Parkinson’s disease , 2003, Neuropsychologia.

[41]  T. Robbins,et al.  Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. , 1993, Brain : a journal of neurology.

[42]  Michael J. Frank,et al.  A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism , 2008, Neuropsychologia.

[43]  Charan Ranganath,et al.  Effects of Unilateral Prefrontal Lesions on Familiarity, Recollection, and Source Memory , 2005, The Journal of Neuroscience.

[44]  A. Grace,et al.  The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes , 2004, Neuropsychopharmacology.

[45]  Stephen McAdams,et al.  Separate Neural Processing of Timbre Dimensions in Auditory Sensory Memory , 2006, Journal of Cognitive Neuroscience.

[46]  D. Durstewitz,et al.  The Dual-State Theory of Prefrontal Cortex Dopamine Function with Relevance to Catechol-O-Methyltransferase Genotypes and Schizophrenia , 2008, Biological Psychiatry.

[47]  松岡 恵子,et al.  日本語版National Adult Reading Test(JART)の作成 , 2002 .

[48]  Adrian M. Owen,et al.  Dopamine-Dependent Frontostriatal Planning Deficits in Early Parkinson ' s Disease , 2004 .

[49]  J. Roulin,et al.  Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication. , 2000, Neuropsychology.

[50]  M. Horstink,et al.  Cognitive and motor shifting aptitude disorder in Parkinson's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[51]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[52]  T. Robbins,et al.  Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. , 2001, Cerebral cortex.

[53]  Boris S. Gutkin,et al.  Dopamine modulation in the basal ganglia locks the gate to working memory , 2006, Journal of Computational Neuroscience.

[54]  Roshan Cools,et al.  Role of Dopamine in the Motivational and Cognitive Control of Behavior , 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[55]  J. Seamans,et al.  The principal features and mechanisms of dopamine modulation in the prefrontal cortex , 2004, Progress in Neurobiology.

[56]  Alan C. Evans,et al.  Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. , 1998, Brain : a journal of neurology.

[57]  J. Stroop.  Studies of interference in serial verbal reactions. , 1992 .

[58]  C. Marsden,et al.  Fronto-striatal cognitive deficits at different stages of Parkinson's disease. , 1992, Brain : a journal of neurology.

[59]  R. Malmo.  INTERFERENCE FACTORS IN DELAYED RESPONSE IN MONKEYS AFTER REMOVAL OF FRONTAL LOBES , 1942 .

[60]  H. E. Rosvold,et al.  Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. , 1979, Science.

[61]  A. C. Roberts,et al.  Perseveration and Strategy in a Novel Spatial Self-Ordered Sequencing Task for Nonhuman Primates: Effects of Excitotoxic Lesions and Dopamine Depletions of the Prefrontal Cortex , 1998, Journal of Cognitive Neuroscience.

[62]  Jeffrey W. Cooney,et al.  Is the Prefrontal Cortex Necessary for Delay Task Performance? Evidence from Lesion and fMRI Data , 2006, Journal of the International Neuropsychological Society.

[63]  G. Borasio,et al.  Palliative therapy in the terminal stage of neurological disease , 1997, Journal of Neurology.

[64]  P. Goldman-Rakic,et al.  D1 dopamine receptors in prefrontal cortex: involvement in working memory , 1991, Science.

[65]  B. Sahakian,et al.  Predictors of punding in Parkinson's disease: Results from a questionnaire survey , 2007, Movement disorders : official journal of the Movement Disorder Society.

[66]  A. Lees.  Cognitive Deficits in Parkinson’s Disease , 1985 .